I'm not saying it's never happened, but I have just never seen a failed phase II trial come down to a labeling error. Pretty far fetched to pin an investment on that idea after the company specifically said that was not what happened and when the majority of trials don't get past phase II anyway.
I'm not saying it's never happened, but I have just never seen a...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $1.150M | 3.188M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 304384 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 256847 | 13 |
View Market Depth
| Last trade - 13.36pm 19/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |